Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista Salud Uninorte
versión impresa ISSN 0120-5552versión On-line ISSN 2011-7531
Resumen
ESPITIA DE LA HOZ, Franklin José y OROZCO GALLEGO, Hoover. Alteration of the sexual response cycle in women using combined oral contraceptives. Salud, Barranquilla [online]. 2018, vol.34, n.2, pp.430-442. ISSN 0120-5552. https://doi.org/10.14482/sun.34.2.613.94.
Objective:
To estimate the effect of female sexuality due to the use of the contraceptive combination estradiol valerate / Dienogest against Ethinylestradiol / Drospirenone.
Material and methods:
A controlled, randomized, unblinded clinical trial was carried out on 174 women, between 18 and 39 years of age, who underwent two hormonal contraceptive options with estradiol valerate / Dienogest and ethinylestradiol / Drospirenone; in a private clinic in Armenia, Quindío, between 2013 and 2017. The female sexual function index (IFSF) was used to analyze the sexual function of the participating women; at the beginning, at six, at eighteen and thirty-six months after the start of the contraceptive.
Results:
At the end of the study, the contraceptive combination estradiol valerate / Dienogest was a less aggressive therapy in the alteration of the sexual response cycle of the users, while the ethinylestradiol / drospirenone combination significantly affects the desire and excitement with lower scores in the IFSF.
Conclusions:
The results indicate that the estradiol valerate / Dienogest combination affects the desire, arousal and IFSF score less than the ethinylestradiol / drospirenone combination.
Palabras clave : Androgens; Contraceptive Agents; Women; Sexuality; Testosterone.